Mealey's (August 12, 2021, 1:14 PM EDT) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Aug. 10 centralized 20 federal lawsuits alleging that the chemotherapy drug Tasigna caused atherosclerotic injuries, citing the centralization of 186 cases in New Jersey state court and plaintiff counsel’s review of more than 200 potential new cases....